Investigations using 5XFAD transgenic AD models carrying APP/PS1 mutations further demonstrated trigonelline's ability to activate creatine kinase B-type (CK-B), promote axonal regeneration, reverse β-Aβ-induced axonal degeneration, and enhance memory function (51). This evidence concerns the gene CKB and Alzheimer disease.